Filter Results:
(64)
Show Results For
- All HBS Web
(64)
- News (30)
- Research (19)
- Multimedia (1)
- Faculty Publications (8)
Show Results For
- All HBS Web
(64)
- News (30)
- Research (19)
- Multimedia (1)
- Faculty Publications (8)
- 06 Dec 2021
- News
Vision: Sound Science
doctorate in biomedical engineering and readily admits he still identifies as a scientist, is equally excited about the big-picture impact of receiving orphan drug and rare pediatric disease designations.... View Details
Keywords: Deb Blagg
- 16 Jul 2019
- News
The Making of a Movement
proceeds from research specific to sarcoma—the disease Jen fought—to all rare cancers. The significance of that selfless shift was seismic. By loosening the link between Cycle for Survival and their own... View Details
- 01 Mar 2006
- News
One-on-One with Dr. Margaret Chan
appointed Representative of the WHO Director-General for Pandemic Influenza last year. She also serves as Assistant Director-General for the Communicable Diseases Cluster. With so much at stake, what keeps Chan focused? “A sheer passion... View Details
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
M.B.A. from Harvard University. You Might Want to Read 24 May 2023 Student Spotlight: 2023 HCC Co-Presidents Reflect on Their Time at HBS and the Current Health Care Systems Morgan Moncada & Hannah Truong 28 Feb 2023 Rare View Details
- 30 Jun 2017
- News
Rebuilding the Girl Scouts Brand
Goals. “I had that rare instance where my skill set as a marketer was being called on to meet a greater social need,” Pitter-Armand says. “I’d always enjoyed my work, but now I was waking up at 3 o’clock in the morning with new ideas.” As... View Details
Keywords: April White
- Web
Entrepreneurs Promise Signers - Alumni
Flare Capital Matt Graham (MBA 2017), Rapid Dev Eric Grossman (MBA 2014), TAIT Shalabh Gupta (MBA 2023), Liber Management Walter Haas (MBA 2014), Sacred Quality LLC Richard Horgan (MBA 2018), Cure Rare View Details
- 24 Sep 2020
- News
The Race for a Vaccine
newly opened facility to accommodate its vaccine development work, and CEO Stéphane Bancel (MBA 2000, AMP 170) welcomed input on the design from the government’s infectious disease experts. For two years, Moderna had been working closely... View Details
- Web
Women, Work, and the “M” Word - Blog: Health Supplement
Student Spotlight: 2023 HCC Co-Presidents Reflect on Their Time at HBS and the Current Health Care Systems Morgan Moncada & Hannah Truong 28 Feb 2023 Rare Disease Day – Small Numbers, Big Challenges and Big... View Details
- 23 Nov 2009
- Research & Ideas
Management’s Role in Reforming Health Care
experiments are underway with professionals trying different ways of configuring and managing services. On that list I include experiments with disease management programs, substituting nurse practitioners for physicians in certain... View Details
- 07 Jan 2008
- Research & Ideas
Pursuing a Deadly Opportunity
entrepreneurial venture. The paper, which offers a rare glimpse into an area where little consolidated data is available, is forthcoming in the journal Social Science & Medicine. "This study happens to focus on cadavers, but it... View Details
- Web
Dean Srikant Datar’s 2023 Commencement Remarks | About
information, to want more market research, or to be paralyzed by uncertainty and ambiguity. Leaders rarely have this luxury. That’s why, in the case discussions that are the central component of the education we offer at Harvard Business... View Details
- 03 Mar 2017
- News
Big Blue’s Big Bet
doctors at least two weeks to sift through these mutations, searching for the ones that were diagnostically significant. But Watson was able to highlight within moments which mutated genes had likely developed into cancer. Based on Watson’s analysis, the treating... View Details
Keywords: Paul Kix; illustrations by Dan Page
- 01 Dec 2017
- News
Alumni and Faculty Books for December 2017
struggles of entrepreneurial pioneers rarely proved profitable, for they were forced to compete with conventional businesses that ignored negative environmental externalities and were often subsidized by governments in the United States... View Details
- 15 Dec 2015
- News
The Year in Ideas 2015
guilt and insecurity. NeuroPhage is a family business of sorts. Jonathan Solomon’s (MBA 2007) mother, Beka Solomon, chair for biotechnology of neurodegenerative diseases at Tel Aviv University, had spent years working with a virus that... View Details
- 01 Sep 2010
- News
Fair Trade
pharmaceuticals and software, and far above the average of all industries. Many apparent paradoxes add to the puzzle posed by the industry. While rarely considered fundamentally “bad,” such as the trade in narcotics or tobacco, the beauty... View Details
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new orphan drugs... View Details
Keywords: Dina Gerdeman
- 29 Apr 2014
- First Look
First Look: April 29
utilizes a very rare "no haggle pricing" strategy and extended sales cycle when selling pieces to collectors. Though it remains profitable and very respected, the size and scope of the gallery will be brought into question when... View Details
Keywords: Sean Silverthorne
- 15 Jun 2021
- News
June 2021 Books and Podcasts
drives; and how to manage the disease and vaccinations in the villages of developing countries. The book also explores how governments across the world can work closely with private-sector companies to fight the illness and accelerate... View Details
- 28 Apr 2009
- First Look
First Look: April 28, 2009
consumer-oriented model for drug development and use has attracted attention in recent years as an alternative to the much-maligned approach of mass-marketing blockbuster drugs. In a parallel development, patients and disease-based organizations have assumed greater... View Details
Keywords: Martha Lagace
- 01 Jun 2018
- News
The Long Run
Jim Langford waits for no squirrel. On a clear January morning in Atlanta, driving with considerable speed and purpose, he barrels up the hill of the Carter Center campus in a 2012 Toyota Camry. He’s talking about poetry, which he writes and publishes in View Details